Impairment of adipose tissue development by hypoxia is not mediated by plasminogen activator inhibitor-1

Summary

Hypoxia in rodents and humans is associated with a reduction of body fat on the one hand, and with enhanced expression of plasminogen activator inhibitor-1 (PAI-1), the main inhibitor of the fibrinolytic system, on the other hand. It was the objective of this study to investigate whether impairment of adipose tissue development by hypoxia may be mediated by PAI-1. Five week old male wild-type (WT) C57Bl/6 mice were fed a standard (SFD) or high fat (HFD) diet and kept under normoxic or hypoxic (10% O₂) conditions. In addition, PAI-1 deficient mice and WT littermates were kept on HFD under normoxia or hypoxia. In vitro, the effect of hypoxia (2% O₂) was investigated on differentiation of 3T3-L1 cells into adipocytes. Hypoxia induced a significant reduction of weight gain in WT mice on either SFD or HFD, accompanied by lower weights of subcutaneous (SC) and gonadal (GON) fat. Under hypoxic conditions, adipocytes in the adipose tissues were significantly smaller, whereas blood vessel size and density were larger. Serum PAI-1 levels were enhanced in hypoxic mice on SFD but not on HFD, and overall did not correlate with the observed changes in adipose tissue composition. Furthermore, the effects of hypoxia on adipose tissue in mice on HFD were not affected by deficiency of PAI-1. The inhibiting effect of hypoxia on in vitro preadipocyte differentiation was not mediated by PAI-1 activity. In conclusion, impairment of in vivo adipose tissue development and in vitro differentiation of preadipocytes by hypoxia is not mediated by PAI-1.

Keywords

Hypoxia - PAI-1 - adipose tissue - obesity - (pre)adipocyte

• References

• 1 Reynolds RD. et al. Energy metabolism increases and regional body fat decreases while regional muscle mass is spared in humans climbing Mt Everest. J Nutr 1999; 129: 1307-14.
• 2 Baum D, Stern MP. Adipose hypocellularity in cyanotic congenital heart disease. Circulation 1977; 55: 916-20.
• 3 Westerterp KR. et al. Energy balance at high altitude of 6,542 m. J Appl Physiol 1994; 77: 862-6.
• 4 Fushiki T. et al. Effects of chronic hypoxia on the whole-body insulin action in rats. Can J Physiol Pharmacol 1992; 70: 1522-4.
• 5 Tanaka M. et al. Effects of exposure to hypobarichypoxia on body weight, muscular and hematological characteristics, and work performance in rats. Jpn J Physiol 1997; 47: 51-7.
• 6 Macfarlane CM. In vitro influence of sublethal hypoxia on differentiation of the 3T3-L1 preadipose cell line and its physiological implications. Life Sciences 1997; 60: 1923-31.
• 7 Sahai A. et al. Chronic hypoxia impairs the differentiation of 3T3-L1 fibroblast in culture: role of sustained protein kinase C activation. J Cell Physiol 1994; 160: 107-12.
• 8 Yun Z. et al. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2002; 02: 331-41.
• 9 Kietzmann T. et al. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 1999; 94: 4177-85.
• 10 Fink T. et al. Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. Blood 2002; 99: 2077-83.
• 11 Samad F. et al. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. J Clin Invest 1996; 97: 37-46.
• 12 Alessi MC. et al. Production of plasminogen activator inhibitor 1 by human adipose tissue. Diabetes 1997; 46: 860-7.
• 13 Èren M. et al. Phenotypic derangements associated with overexpression of plasminogen activator inhibitor-1 (PAI-1) in transgenic mice. Arterioscler Thromb Vasc Biol 2001; 21: 695.
• 14 Lijnen HR. et al. Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 2003; 23: 78-84.
• 15 Ma L-J. et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 2004; 53: 336-46.
• 16 Morange PE. et al. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 2000; 20: 1150-4.
• 17 Lijnen HR. Effect of plasminogen activator inhibitor-1 deficiency on nutritionally induced obesity in mice. Thromb Haemost 2005; 93: 816-9.
• 18 Schafer K. et al. Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 2001; 15: 1840-2.
• 19 Giles AR. Guidelines for the use of animals in biomedical research. Thromb Haemost 1987; 58: 1078-84.
• 20 Gils A. et al. Biochemical importance of glycosylation of plasminogen activator inhibitor-1. Thromb Haemost 2003; 90: 206-17.
• 21 Maquoi E. et al. Modulation of the expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002; 51: 1093-101.
• 22 Demeulemeester D. et al. Effect of matrix metalloproteinase inhibition on adipose tissue development. Biochem Biophys Res Commun 2005; 329: 105-10.
• 23 Laitinen L. Griffonia Simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem J 1987; 19: 225-34.
• 24 Lijnen HR. et al. Function of plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 1998; 18: 1035-45.
• 25 Declerck PJ. et al. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb Haemost 1995; 74: 1305-9.
• 26 Grosfeld A. et al. Hypoxia increases leptin expression in human PAZ6 adipose cells. Diabetologia 2002; 45: 527-30.
• 27 Lolmède K. et al. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes 2003; 27: 1187-95.
• 28 Yu AY. et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxiainducible factor 1. J Clin Invest 1999; 103: 691-6.
• 29 Carriere A. et al. Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J Biol Chem 2004; 279: 40462-9.
• 30 Zhou S. et al. Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires TGFbeta/Smad3 signaling. J Biol Chem 2005; 280: 22688-96.
• 31 Skurk T, Hauner H. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int J Obesity 2004; 28: 1357-64.
• 32 Fitzpatrick TE, Graham CH. Stimulation of plasminogen activator inhobitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen. Exp Cell Res 1998; 245: 155-62.
• 33 Saed GM, Diamond MP. Modulation of the expression of tissue plasminogen activator and its inhibitor by hypoxia in human peritoneal and adhesion fibroblasts. Fert Steril 2003; 79: 164-8.
• 34 Uchiyama T. et al. Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20: 1155-61.
• 35 Fink T. et al. Quantitative gene expression profiles of human liver-derived cell lines exposed to moderate hypoxia. Cell Physiol Biochem 2001; 11: 105-14.
• 36 Zhang QZ. et al. Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 2003; 121: 1005-12.
• 37 Pinsky DJ. et al. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 1998; 102: 919-28.
• 38 Kietzmann T. et al. Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases. Thromb Haemost 2003; 89: 666-73.
• 39 Zhang Q. et al. Crosstalk of hypoxia-mediated signaling pathways in upregulating plasminogen activator inhibitor-1 expression in keloid fibroblasts. J Cell Physiol 2004; 199: 89-97.
• 40 Davi G. et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002; 288: 2008-14.
• 41 Furukawa S. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 14: 1752-61.
• 42 Hlatky L. et al. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Natl Cancer Inst 2002; 94: 883-93.
• 43 Cao R. et al. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 2001; 98: 6390-5.
• 44 Auwerx J, Bart S. Leptin. Lancet 1998; 351: 737-42.
• 45 Schwartz MW. et al. Central nervous system control of food intake. Nature 2000; 404: 661-71.
• 46 Tshöp M. et al. Raised leptin concentrations at high altitude associated with loss of appetite. Lancet 1998; 352: 1119-20.
• 47 Raff H. et al. The effect of hypoxia on plasma leptin and insulin in newborn and juvenile rats. Endocrine 1999; 11: 37-9.
• 48 Norese MF. et al. Failure of polycythemia-induced increase in arterial oxygen content to suppress the anorexic effect of simulated high altitude in the adult rat. High Alt Med Biol 2002; 03: 49-57.
• 49 Woolcott OO. et al. Serum leptin levels in dwellers from high altitude lands. High Alt Med Biol 2002; 03: 245-6.
• 50 Vats P. et al. Leptin may not be responsible for high altitude anorexia. High Alt Med Biol 2004; 05: 90-2.
• 51 Sierra-Honigmann MC. et al. Biologic action of leptin as an angiogenic factor. Science 1998; 281: 1683-6.
• 52 Lijnen HR. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 2005; 03: 35-45.
• 53 Crandall DL. et al. Autocrineregulation of human preadipocyte migration by plasminogen activator inhibitor-1. J Clin Endocrinol Metab 2000; 85: 2609-14.
• 54 Crandall DL. et al. A review of the microcirculation of adipose tissue: anatomic, metabolic and angiogenic perspectives. Microcirculation 1997; 04: 211-32.